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For many  years studies on  the regulation  of  gene ex-
pression  have  focused  on  the  control  of transcription, 
thinking that once the gene was expressed as mRNA it 
would be translated and when its time was up it would 
simply be degraded in the cytoplasm. However, recent 
years have seen increasing interest in mechanisms in-
volved  in  the  post-transcriptional  regulation  of  gene 
expression.  An  important  aspect  of  this  explosion  in 
interest  has  been  the  discovery  that  small  regulatory 
RNA molecules, small interfering (si) RNAs and micro 
(mi) RNAs, are capable of inhibiting  gene expression 
by  either  directing  the  degradation  of  homologous 
mRNA targets or inducing the repression of translation 
of mRNA targets which have incomplete complemen-
tarity. Extensive biochemical and genetic analysis has 
helped  to  shed  light  on  the  mechanism  by  which 
siRNAs are incorporated into the RNA-induced silenc-
ing  complex  (RISC),  recognize  the  target  mRNA  and 
directing its cleavage. This has been  greatly aided by 
recent studies on the crystal structure of a siRNA guide 
strand associated with Piwi, the Piwi domain of Argo-
naute  2  (Ago2)  being  responsible  for  recognition  and 
endonucleolytic cleavage of the target mRNA. Despite 
being  the  first  post-transcriptional  gene  silencing 
mechanism to be identified, much less is known about 
the mechanism of translational repression compared to 
the targeted degradation of mRNA. It is possible to en-
vision  a  variety  of  potential  mechanisms  by  which 
RISC could induce the inhibition of translation, includ-
ing the impairment of steps in the process of translation 
(for example, blocking the progress of ribosomes along 
the mRNA) or the “tagging” of newly formed proteins 
for  degradation.  In  fact,  an  alternative  mechanism  of 
translation  repression,  that  of  sequestering  the  target 
mRNA  into  distinct  sites  within  the  cytoplasm  and 
away  from  the  translational  machinery,  has  been  the 
focus of a number of recent studies. 
 
These sites in the cytoplasm, referred to by a variety of 
names  including  processing  (P)-,  cytoplasmic-,  GW-, 
Dcp-, or Lsm-bodies, serve as foci for the accumulation 
of mRNAs that are destined for storage or degradation. 
In addition to the mRNA component, these site contain 
the mRNA decapping enzymes (Dcp1/Dcp2), essential 
components of the mRNA degradation pathway, as well 
as, additional proteins, including the 5’-3’ exonuclease, 
Xrn1, Dhh1p, Pat1p and in mammalian cells, GW182 
(Coller and Parker, 2004; Sen and Blau, 2005). The first 
hint  of  the  interaction  of  the  miRNA  machinery  with 
these  sites  of  mRNA  turnover  was  the  demonstration 
that the mammalian Ago proteins (Ago1, -2, -3 and -4) 
were  concentrated  into  discrete  foci  in  the  cytoplasm 
which colocalized with components of the mammalian 
P-bodies, GW182, Dcp1a and 2 (Sun and Blau, 2005; 
Liu  et al,  2005a).  Interestingly,  members of  a second 
family of Argonaute proteins, the Piwi family, that have 
not been found to be associated with miRNAs did not 
show this localization pattern (Liu et al, 2005a). Bio-
chemical analysis demonstrated a direct physical inter-
action between components of RISC and the mammal-
ian  P-bodies  since  Dcp1  and  2  could  co-
immunoprecipitate with Ago1 and Ago2. In the absence 
of  RNA,  these  factors  retained  the  ability  to  co-
immunoprecipitate    (Liu  et  al,  2005a),  however,  they 
failed to localize to the P-bodies (Sun and Blau, 2005). 
This data indicates that the Ago proteins could interact 
with the P-body components independently of their in-
corporation into the discrete foci. In addition, mutations 
in the PAZ domain of Ago2 that inhibit its ability to 
bind to siRNAs and miRNAs did not affect the interac-
tion of Ago2 with Dcp1a but did prevent their localiza-
tion to P-bodies, demonstrating that the localization of 
Ago2  into  the  P-bodies  was  a  miRNA-/siRNA-
dependent process. This was further confirmed by fol-
lowing the fate of reporter mRNAs containing multiple 
MS2 binding sites that can be visualized by the intro-
duction  of  a  fluorescently  tagged  MS2  protein  (MS2-
YFP)  and  sites  for  either the  endogenously expressed 
let-7  miRNA  or  an  exogenously  introduced  siRNA 
(CXCR4)  that mimics  miRNA function  by  binding  to  
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multiple  imperfectly  complementary  sites  on  the 
mRNA.  The  tagged  mRNAs  were  localized  in  the  P-
bodies in the presence of their respective miRNA, but 
not in the absence of the miRNA or in reporter mRNAs 
that lacked the miRNA binding sites. Although this data 
showed a linkage between the components of the silenc-
ing machinery and localization to the P-bodies it pro-
vided  no  evidence  of  the  functional  necessity  of  this 
localization for gene silencing. This was quickly reme-
died by two studies that provided a functional link be-
tween P-bodies and RNAi-mediated silencing (Liu et al, 
2005b; Jakymiw et al, 2005). They found that the si-
lencing of GW182 by treatment with siRNAs impaired 
the formation of P-bodies. In fact, there was a striking 
lack  of  P-bodies  in  the  GW182  siRNA  treated  cells, 
demonstrated the critical role that GW182 plays in the 
organization and architecture of these structures. More 
importantly for the determination of the mechanism of 
RNAi-mediated  silencing,  the  disruption  of  the  P-
bodies  significantly  impaired  both  miRNA-  (transla-
tional repression) and siRNA- (mRNA cleavage) medi-
ated silencing. This was found to be the case for both 
the silencing of exogenous miRNA and siRNA reporter 
gene  (Liu et  al,  2005b)  and  for endogenous  gene  ex-
pression (Jakymiw et al, 2005). 
 
The physical  and  functional link  between  the sites  of 
mRNA turnover/storage and miRNA-/siRNA-mediated 
silencing raises interesting questions not only about the 
mechanism of RNAi-mediated silencing but the poten-
tial role that RNAi or components of the RNAi machin-
ery  may  play  in  other  translational  regulation  mecha-
nisms. P-bodies, far from being the site of mRNA deg-
radation alone, are increasingly thought to be sites for 
the  storage  of  translationally  repressed  mRNAs,  with 
mRNAs being able to move between the active and in-
active pool as needed. One hypothesis put forward by 
the  Parker  and Hannon  groups  suggests  that  miRNAs 
may  mediate  their  repressive  function  by  selectively 
transporting and possibly even maintaining their mRNA 
targets in these sites of translational repression segre-
gated  from  the  translational  machinery.  Though  far 
from providing a complete answer these studies repre-
sent  an  important  step  in  our  understanding  of  the 
miRNA-mediated repression of translation. 
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